Faculty Opinions recommendation of Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease.
2019 ◽
Vol 33
(7)
◽
pp. 468-472
◽
2019 ◽
Vol 6
◽
pp. 205435811985411
2008 ◽
Vol 19
(1)
◽
pp. 4-7
◽
2014 ◽
Vol 2
(1)
◽
pp. e000011
◽